Clinical Trials
12 trialsNCT07428954 2026-02-24
LegitHealthSAN
AI Labs Group S.L
Completed
NCT03284879 2025-09-08
Post-Marketing Surveillance Study of OTEZLA
Amgen
Completed
NCT05796245 2025-06-04
A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or Psoriasis
Pfizer
Completed
NCT00368784 2025-05-14
T Cell Repertoire Analysis of Immune Mediated Skin Diseases
University of California, Davis
Completed
NCT01931644 2024-04-18
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Sanguine Biosciences
Completed
NCT03941184 2020-11-23
Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity
Mayo Clinic
Completed
NCT03253666 2020-07-15
Nurses' Health Study and Health Professionals Follow-Up Study (Dermatological Component)
Harvard School of Public Health (HSPH)
Completed
NCT00710489 2019-02-15
Potential Research Study Participant Registry
University of California, Davis
Completed
NCT02376478 2015-03-03
On the Impact of Therapeutic Tumor Necrosis Factor-alpha Inhibition on Anogenital Human Papillomavirus Infection
Medical University of Vienna
Completed
NCT01126619 2012-10-25
A Study of Effectiveness and Safety of Tumor Necrosis Factor (TNF) Inhibitors in Patients With Moderate to Severe Psoriasis
Abbott
Completed
NCT00005660 2008-03-04
The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive Diseases
National Institutes of Health Clinical Center (CC)
Completed
NCT00005781 2008-03-04
Assessment of Digital Imaging as a Tool for Diagnosing Psoriasis, Hand Rashes and Unusual Moles
National Institutes of Health Clinical Center (CC)
Completed